Literature DB >> 14590156

Neuropsychological performance deficits in adults with attention deficit/hyperactivity disorder.

D E Johnson1, J N Epstein, L R Waid, P K Latham, K E Voronin, R F Anton.   

Abstract

Neuropsychological deficits in children diagnosed with attention deficit/hyperactivity disorder (ADHD) have been well documented utilizing various neuropsychological tests. Only recently has research begun to examine if similar deficits are present in adults with ADHD. A neuropsychological testing battery was constructed that assessed verbal learning and memory, psychomotor speed, and sustained attention--all demonstrated to be deficient in individuals with ADHD. Fifty-six self-referred nonmedicated adults with a DSM-IV diagnosis of ADHD and 38 normal comparison adults participated. ADHD adults demonstrated verbal and nonverbal memory deficits and decreased psychomotor speed compared to normal controls. Differences between ADHD and normal adults were not documented on traditional measures of executive functioning. A pattern of results emerged whereby ADHD adults' performance, particularly with regard to psychomotor speed, became more impaired as task complexity increased. This study's results largely corroborate similar neuropsychological testing results in ADHD children and recent ADHD adult findings, and support a frontal lobe dysfunction hypothesis of ADHD.

Entities:  

Year:  2001        PMID: 14590156

Source DB:  PubMed          Journal:  Arch Clin Neuropsychol        ISSN: 0887-6177            Impact factor:   2.813


  16 in total

1.  Are motor inhibition and cognitive flexibility dead ends in ADHD?

Authors:  Nanda N J Rommelse; Marieke E Altink; Leo M J de Sonneville; Cathelijne J M Buschgens; Jan Buitelaar; Jaap Oosterlaan; Joseph A Sergeant
Journal:  J Abnorm Child Psychol       Date:  2007-05-15

2.  FAS and CFL forms of verbal fluency differ in difficulty: a meta-analytic study.

Authors:  Danielle Barry; Marsha E Bates; Erich Labouvie
Journal:  Appl Neuropsychol       Date:  2008

3.  Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder.

Authors:  O Tucha; L Mecklinger; R Laufkötter; H E Klein; S Walitza; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

4.  Which components of processing speed are affected in ADHD subtypes?

Authors:  Michelle Y Kibby; Sarah A Vadnais; Audreyana C Jagger-Rickels
Journal:  Child Neuropsychol       Date:  2018-12-18       Impact factor: 2.500

5.  Comparison of verbal learning and memory in children with heavy prenatal alcohol exposure or attention-deficit/hyperactivity disorder.

Authors:  Nicole Crocker; Linnea Vaurio; Edward P Riley; Sarah N Mattson
Journal:  Alcohol Clin Exp Res       Date:  2011-03-15       Impact factor: 3.455

6.  Set shifting and working memory in adults with attention-deficit/hyperactivity disorder.

Authors:  Helena Rohlf; Viola Jucksch; Caterina Gawrilow; Michael Huss; Jakob Hein; Ulrike Lehmkuhl; Harriet Salbach-Andrae
Journal:  J Neural Transm (Vienna)       Date:  2011-05-31       Impact factor: 3.575

7.  Basic processes as foundations of cognitive impairment in adult ADHD.

Authors:  Marah Butzbach; Anselm B M Fuermaier; Steffen Aschenbrenner; Matthias Weisbrod; Lara Tucha; Oliver Tucha
Journal:  J Neural Transm (Vienna)       Date:  2019-07-18       Impact factor: 3.575

8.  Risk of injury associated with attention-deficit/hyperactivity disorder in adults enrolled in employer-sponsored health plans: a retrospective analysis.

Authors:  Paul Hodgkins; Leslie Montejano; Rahul Sasané; Dan Huse
Journal:  Prim Care Companion CNS Disord       Date:  2011

Review 9.  [Minimal cerebral dysfunctions and ADHD in adulthood].

Authors:  M Linden; J Weddigen
Journal:  Nervenarzt       Date:  2016-11       Impact factor: 1.214

Review 10.  Methylphenidate for attention problems in epilepsy patients: Safety and efficacy.

Authors:  Beth A Leeman-Markowski; Jesse Adams; Samantha P Martin; Orrin Devinsky; Kimford J Meador
Journal:  Epilepsy Behav       Date:  2020-12-24       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.